EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Frasers (FRAS LN) UK

Consumer Discretionary

Holland Advisors

Stepping into the light - share price jumps following the company’s FY update. Long-term bull Andrew Hollingworth thinks the rerating has only just begun. This is a company that has been through an extensive period of re-invention and investment. Its accounting has been uber prudent especially with reference to inventory and its store portfolio. Almost all investors have been referencing potential profitability vs. that recorded in this investment period. This has been an error. It has always been likely that post investment period margins would be better than its past peaks, due to discounting then and elevation now. TP £13.00+ (45%+ upside).

Edition: 141

- 05 August, 2022


Frasers Group (FRAS LN) UK

Consumer Discretionary

Holland Advisors

A forgotten and neglected share - few investors take the company seriously and fewer properly think through its market position and what it could become/the profits it could produce. Andrew Hollingworth discusses the margin recovery story underway and why he believes the price of the employee earn-out (£10.00) and Mike Murray’s new incentive (£15.00 in just 4-yrs) are realistic targets despite the startling difference when compared to today’s share price of 680p. FRAS remains a high conviction Buy.

Edition: 118

- 03 September, 2021